Where contamination control often begins earlier than expected

A large part of contamination control is shaped before anyone enters a controlled environment.

In the previous blog, we looked at contamination control through a physical environment lens. We walked the sites, reviewed flows and examined how operational realities shape risk in practice. 

The next step took us somewhere less technical, but no less relevant. 

As manufacturers implement EU GMP Annex 1 requirements, responsibility for contamination control extends across the supply chain. Suppliers are increasingly expected to demonstrate how their own operations contribute to product quality, providing greater confidence through robust processes, controls and supporting data. 

For Aptar Pharma Injectables, this also meant looking more closely at how behavior influences contamination control before it becomes measurable or visible through standard systems. 

In practice, contamination control often starts earlier than expected. 

Looking beyond the cleanroom 

When contamination control is discussed, attention often goes to classified environments, isolators or monitoring systems. These are essential, but they represent only part of the picture. 

A significant part of contamination control for our pre-filled syringe components and vial containment solutions is shaped before entering controlled environments. It lies in routines, dress discipline, team interactions and the consistency with which expectations are applied. 

This became clear in our work. If Contamination Control Strategy (CCS) reflects how risks are managed in practice, then behavior needs to be treated as part of that system. 

What we put in place 

This led Aptar Pharma to structure behavioral expectations more explicitly. 

Internally, this took shape through what we described as a structured ‘code of practice’ for behavior. The objective was to define consistent, visible expectations linked directly to contamination control. 

Work focused on hygiene and gowning discipline, behavior in controlled environments, change management, escalation practices and cleaning routines. 

These topics were already part of GMP practices, but they were not always applied with the same level of structure and consistency. Making that consistent brought them much closer to everyday operations. 

This was supported by a focused training effort. More than 250 managers were trained on quality culture through structured sessions, reinforcing a consistent interpretation of expectations across sites. 

In parallel, gowning practices were further aligned, including the introduction of a standardized approach from entry into production areas. 

What this revealed 

A few observations from this phase may also be useful beyond our own operations. 

Behavior needs to be treated as part of the control system. When it remains only a matter of awareness, it becomes difficult to sustain consistently. 

Routine practices play a significant role. Small variations in discipline or escalation habits can gradually shape the operating environment. 

Leadership consistency is a key factor. Expectations need to be applied visibly and consistently for the system to remain coherent. 

More broadly, contamination control is not only technical. It is also operational and part of that operation is human routine. 

For readers across pharma manufacturing and the supply chain, making behavioral expectations concrete early on, helps maintain consistency where it matters most. 

Looking ahead 

This phase clarified that contamination control is reinforced not only through systems and design, but also through routines and day-to-day discipline. 

In the next blog, we will explore how audits and observations evolved to support ongoing operational control rather than only verification for Aptar Pharma Injectables.